Skip to main navigation Skip to search Skip to main content

Off-Label use of Woven EndoBridge device for intracranial brain aneurysm treatment: Modeling of occlusion outcome

  • WorldWideWEB Consortium Collaborators
  • Albert Einstein College of Medicine
  • Mayo Clinic Rochester, MN
  • Louisiana State University in Shreveport
  • University of Toronto
  • Brigham and Women’s Hospital
  • Ankara University
  • CHU de Toulouse
  • Université libre de Bruxelles
  • Azienda Ospedaliera Careggi
  • Cornell University
  • University of Lausanne
  • Thomas Jefferson University
  • Sorbonne Université
  • Heidelberg University 
  • Universitätsklinikum Christian Doppler Klinik Salzburg
  • New York University
  • University of Pennsylvania
  • Equipo de Neuro. End. y Radiol. Inter. de Buenos Aires-Clin. la Sagrada Familia
  • Orlando Regional Medical Center
  • Cooper University Health Care
  • Sisters of Charity Hospital
  • Baylor College of Medicine
  • St. Joseph's Hospital and Medical Center, Phoenix
  • SUNY Buffalo
  • Austin Health
  • Geisinger
  • Asst Grande Ospedale Metropolitano Niguarda
  • University of Massachusetts Medical School
  • Scientific Institute University Hospital San Rafaele
  • University of Miami
  • Valley Baptist Neuroscience Institute
  • University of Alabama at Birmingham
  • University of Basel
  • University of Hamburg

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Introduction: The Woven EndoBridge (WEB) device is emerging as a novel therapy for intracranial aneurysms, but its use for off-label indications requires further study. Using machine learning, we aimed to develop predictive models for complete occlusion after off-label WEB treatment and to identify factors associated with occlusion outcomes. Methods: This multicenter, retrospective study included 162 patients who underwent off-label WEB treatment for intracranial aneurysms. Baseline, morphological, and procedural variables were utilized to develop machine-learning models predicting complete occlusion. Model interpretation was performed to determine significant predictors. Ordinal regression was also performed with occlusion status as an ordinal outcome from better (Raymond Roy Occlusion Classification [RROC] grade 1) to worse (RROC grade 3) status. Odds ratios (OR) with 95 % confidence intervals (CI) were reported. Results: The best performing model achieved an AUROC of 0.8 for predicting complete occlusion. Larger neck diameter and daughter sac were significant independent predictors of incomplete occlusion. On multivariable ordinal regression, higher RROC grades (OR 1.86, 95 % CI 1.25-2.82), larger neck diameter (OR 1.69, 95 % CI 1.09-2.65), and presence of daughter sacs (OR 2.26, 95 % CI 0.99-5.15) were associated with worse aneurysm occlusion after WEB treatment, independent of other factors. Conclusion: This study found that larger neck diameter and daughter sacs were associated with worse occlusion after WEB therapy for aneurysms. The machine learning approach identified anatomical factors related to occlusion outcomes that may help guide patient selection and monitoring with this technology. Further validation is needed.

Original languageEnglish
Article number107897
JournalJournal of Stroke and Cerebrovascular Diseases
Volume33
Issue number11
DOIs
StatePublished - Nov 2024

Keywords

  • Aneurysms
  • Intracranial
  • Off-Label
  • WEB
  • Woven EndoBridge

Fingerprint

Dive into the research topics of 'Off-Label use of Woven EndoBridge device for intracranial brain aneurysm treatment: Modeling of occlusion outcome'. Together they form a unique fingerprint.

Cite this